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ABSTRACT 
The potential power provided and possibilities presented 
by computation graphs has steered most of the available 
modeling techniques to re-implementing, utilization and 
including the complex nature of System Biology (SB). 
To model the dynamics of cellular population, we need 
to study a plethora of scenarios ranging from cell 
differentiation to tumor growth and etcetera.  
Test and verification of a model in research means 
running the model multiple times with different or in 
some cases identical parameters, to see how the model 
interacts and if some of the outputs would change 
regarding different parameters.  
In this paper, we will describe the development and 
implementation of a new agent-based model using 
Python. The model can be executed using a development 
environment (based on Mesa, and extremely simplified 
for convenience) with different parameters. The result is 
collecting large sets of data, which will allow an in-depth 
analysis in the microenvironment of the tumor by the 
means of network analysis. 
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1. INTRODUCTION 
At the cellular level, Systems Biology (SB) is mainly a 
complex natural phenomenon that today has become 
important for research in certain areas such as drug 
development and biotechnological productions and 
applications.  
Mathematical models of cellular level are built in bio 
repeated cycles at a portion of time to arrive at a decision. 
The primary idea behind the bio iterative cycles is to 
develop systems by allowing software developers to 
redesign and translate the cellular metabolism. The 
objective is bringing the desired decision or result closer 
to discovery in each iteration; these experiments on 
multi-scale iterative cycle of computational modeling -
besides experimental validation and data analysis- would 
produce incremental samples for the high-throughput 
technologies.  
Also the behavior of the cell emerges at the network-
level and requires much integrative analysis. Moreover, 
due to the size and complexity of intercellular biological 
networks, computational model should be a considerate 
part of the production or application.  
In the following whole simulation challenges, SB would 
not be needless of developing integrated frameworks for 
analysis and data management.  Alongside the 
intercellular level, many researches in SB also address 
the issue of cellular population. 
In evolutionary versions of these scenarios, modeling the 
interactions of these type of models across large multi-
scale would need agent-based modeling. Each agent has 
a Boolean network for its own expression, much like a 
gene. So a proper production or application for SB must 
support not only a compatible simulation method but also 
suitable methods for model parameter estimations which 
represent the experimental data (D.2011; An2008).  
Therefore, ABMs start with rules and mechanisms to 
reconstruct through the mathematical or computational 
form and observe the pattern of data. Processing the 
heterogeneous behavior of individual agent within a 
dynamic population of agents -which cannot be 
controlled by an overall controller- needs a higher-level 
system parallelism which ABMs supports.  
Biological systems include random behaviors and ABMs 
accommodate this via generation of population agents in 
the agent’s rules.  
ABMs have a level of abstraction to create new cellular 
states or environmental variables without changing core 
aspects of the simulation. To aggregate the paradoxical 
nature of emergent behavior which could be observed 
from any agent in contrast to a conceptual rules of the 
model, ABMs reproduce emergent behavior. Emergent 
behavior has a range of stochasticity similar to real world 
Systems Biology (Bonabeau2002). 
Finding software platforms for scientific agent-based 
models require comparing certain software design 
parameters such as emulating parallelism, and 
developing schedulers for multiple iterations, which 
manage ABM run. 
Many references reviewed and compared different agent-
based modeling toolkits. However, from the perspective 
of biotechnological application and biotechnologists, 
most of them share a key weakness. It is using complex 
languages which are not Python. Perhaps re-
implementing ABMs in Python would be a wiser 
technical strategy since it is becoming the language of 
scientific computing, facilitating the web servers for 
direct visualization of every model step, debugging and 
developing an intuition of the dynamics that emerge from 
the model, also allowing users to create agent-based 
models using built-in core components such as agent 
schedulers and spatial grids (Villadsen and Jensen 2013). 
 
2. BACKGROUND 
Spontaneous tumor, which progresses from the initial 
lesion to highly metastatic forms are generally profiled 
by molecular parameters such as prognosis response, 
morphology and pathohistological characteristics. 
Tumors can induce angiogenesis and lymph-
angiogenesis, which plays an important role in 
promoting cancer spread. Previous studies have shown 
that the cancer stem cell (CSC) theory could become a 
hypothesis for tumor development and progression. 
 These CSCs have the capability of both self-renewal and 
differentiation into diverse cancer cells, so one small 
subset of cancer cells has characteristics of stem cells as 
their parents. Hereditary characteristics play a certain 
role in malignant proliferation, invasion, metastasis, and 
tumor recurrence.  
In recent researches the possible relationship between 
cancer stem cells, angiogenesis, lymph-angiogenesis, 
and tumor metastasis is becoming a challenge. Due to 
many evidences and reviews such as (Li 2014; Weis and 
Cheresh 2011; Carmeliet, P., & Jain, R. K. 2000), 
metastasis is defined as the spread of cancer cells from 
the site of an original malignant primary tumor to one or 
more other places in the body. More than 90% of cancer 
sufferings and death is associated with metastatic 
spread. In 1971, Folkman proposed that tumor growth 
and metastasis are angiogenesis-dependent, and hence, 
blocking angiogenesis could be a strategy to intercept 
tumor growth.  
His hypothesis later confirmed by genetic approaches. 
Angiogenesis occurs by migration and proliferation of 
endothelial cells from original blood vessels (Weis and 
Cheresh 2011).  
Accordingly, translational cancer research has 
contributed to the understanding of the molecular and 
cellular mechanisms occurring in the tumor and in its 
microenvironment which causes metastasis and this 
could present a model relatively similar to physiology of 
human or at least has the capability of going 
through genetic manipulations that bring them closer to 
humans. Hence tumor modeling with a high 
spatiotemporal resolution combined with parametric 
opportunities has been rapidly applied in technology 
(Granger and Senchenkova 2010). 
 
2.1. Agent-based Models in Systems Biology 
A primary tumor model addressing the avascular growth 
state depends on differential equations. They are 
classified as “lumped models” to predict the temporal 
evolution of overall tumor size. Since lumped models 
just provide a quantitative prediction of tumor size over 
time with only a few parameters and very low 
computational results, they would not be enough for an 
explicit investigation of many other events such as 
spatiotemporal dynamics of oxygen and nutrients or cell 
to cell interactions; also, stromal cells which play a major 
role in cancer growth and progression in the interaction 
with tumor cells. The result is disregarding the mutations 
in the tumor microenvironment and metastasis. 
These shortcomings lead us to In Silico models of tumor 
microenvironment. In Silico (Edelman, Eddy & Price 
2010) refers to computational models of biology and it 
has many applications. It is an expression performed on 
a computer simulation. In Silico models are divided to 
three main categories (Thorne, Bailey, & Peirce 2007; 
Soleimani et al., 2018):  
 
1. Continuum based models which solve the 
spatiotemporal evolution problems of density 
and concentration of cellular population in the 
tumor microenvironment. 
2. Discrete or agent based on a set of rules which 
change the cells’ states and manage the cells’ 
interactions within the tumor 
microenvironment. 
3. Adaptive Hybrid models which integrate the 
above solutions. 
 
Mathematical and computational models of the tumor 
should cover different aspects of tumor interactions in its 
microenvironment. Most of the avascular tumor models 
address the tumor growth dynamics not taking into 
account the angiogenesis setting; but computational 
models have started research on tumor-induced 
angiogenesis since the beginning of cancer research.  
Therefore, the angiogenesis models have a very strong 
background in experimental observations. The most 
established researches have explicitly focused on the 
stromal cells to achieve a close computational model of 
angiogenesis. 
 For example, according to Monte Carlo simulations and 
energy minimization, cellular models are expanded and 
elaborated on cellular automata to allocate more than one 
lattice site to each cell and describe cell to cell and tumor 
stroma interactions. Nevertheless, building a bulky 
model over a range of matrix densities -which covers 
numerous factors for a large domain size and 3D 
simulations- is restricted by computational and 
application costs. 
Based on a paper written by Soleimani et al. (2018), a 
minimal coupling of a vascular tumor dynamics to tumor 
angiogenic factors through agent-based modeling has 
progressed the experimental studies in the recent years. 
They have mentioned in both reviews that it is 
challenging to mathematically simulate all the process of 
a complex system such as tumor growth, metastasis and 
tumor response treatments, because mathematical 
modeling is still a simplification of the system biology 
and the results requires validation.  
Also, building a predictive experimental plus theoretical 
application without clinical data requires parametrizing 
and validating again. The best improvement which is 
expected would be predictive modeling in both 
preclinical and clinical states (Thorne, Bailey, & Peirce 
2007).  
 
2.2. Complex Networks in Biological Models 
Another interesting approach is the network models. 
Networks follow patterns and rules and have a specific 
topology, which allows scientists to go through with a 
deeper investigation towards biology information 
extraction.  
Within the fields of biology and medicine, Protein-
protein interaction (PPI) networks, biochemical 
networks, transcriptional regulation networks, signal 
transduction or metabolic networks are the highlighted 
network categories in systems biology which could 
detect early diagnosis.  
All these networks need compatible data to be produced 
experimentally or retrieved from various databases for 
each type of network; but besides analyzing data 
structures for computational analysis, several topological 
models have been built to describe the global structure of 
a network (Girvan, Newman 2002; 2004). 
 
3. MODELING AND SIMULATION  
Our approach to the generation of an ABM model 
considered different temporal and spatial scales, focusing 
first on mitosis as the main axis of tumor growth. This 
model and its analysis developed in Netlogo (section 
3.1). Then large number of environment limitations were 
detected with a high number of agents and difficulties to 
analyze the microenvironment of emergent growth. The 
second approximation is presented in this paper (section 
3.2) used dynamic networks based on a large number of 
interactive agents. This model makes it possible to help 
researchers in carrying out more detailed research on 
intercellular network interactions and metastasis in a 
multiple scale model (Grimm2005). 
 
3.1. Netlogo Model and Experimental Results 
Our ABM NetLogo model is designed as a self-
organized model that illustrates the growth of a tumor 
and how it resists chemical treatment. 
 This model in NetLogo (based on Wilensky’s tumor 
model (Wilensky 1999)) permits us to change the 
parameters that affect tumor progression, immune 
system response, and vascularization. Outputs included 
the number of living tumor cells and the strength of the 
immune system which control cells. In this model the 
tumor has two kinds of cells: stem cells and transitory 
cells. In the model, tumor cells are allowed to breed, 
move, or die.  
The simulation presented cells’ control with different and 
constant immune responses through killing transitory 
cells, moving stem cells and original cells.  
Figure 1 shows the steady state of a tumor metastasis 
visualization with 6 stem cells and the grow-factor =1.75, 
replication-factor=high, and apoptosis=low.  
As it could be seen, the growth of metastasis is more 
aggressive and through reducing apoptosis, there is a 
greater number of cells that do not die, amounting to near 
200,000 cells (agents) (Tashakor, Luque & Suppi, 2017).  
The main problem with this implementation was the 
limitations of the execution environment (Java memory 
limitations) and loss of performance with a high number 
of metastasis cells. In addition, this model did not allow 
capturing in detail the interactions between the different 
parameters at the microenvironment level. 
 
 
Figure 1: stem cells evolution and metastasis 
visualization with grow-factor=1.75, apoptosis=low and 
replication-factor=high (near 200,000 cells in steady 
state). 
 
3.2. Python Model and Experimental Results 
 To solve the aforementioned problems, we started a new 
development using Python +Mesa. Mesa is the agent-
based Python project, which has started recently and it 
has rapidly found its place among the researchers. Mesa 
is modular and its modeling, analysis and visualization 
components are integrated and simple to use.  
This feature convinced us to re-implement our tumor 
model with Mesa network structure. Furthermore, it 
supports multi-agent and multi-scale simulations, which 
is suitable for creating dynamic agent-based models. 
This paper documents our work with the Python +Mesa 
to design an agent model based on the tumor model 
scenario.  
At the beginning, Mesa was just a library for agent-based 
modeling in Python but now it is a new open-source, 
Apache 2.0 licensed package meant to fill the gap in the 
modeling complex of dynamical systems.  
In Mesa, the Model class to define the space where the 
agents evolve handles the environment of an agent-based 
model. The environment defines a scheduler which 
manages the agents at every step.  
For studying the behavior of model under different 
conditions, we needed to collect the relevant data of the 
model while it was running; Data Collector class was 
defined for this task. The adapting modules of Mesa 
allow us to make changes in the existing ABMs for the 
purpose of conforming with the requirements of our 
future framework.  
Also, monitoring the data management issues when 
processing actions happen in parallel seems facile in 
Mesa, since each module has a Python part which runs 
on the server and turns a model state into JSON data 
(Masad & Kazil, 2015). The advantage of Mesa is its 
browser for visualization which allows the user to see the 
model while running in the browser.  
Tumor progression is a complex multistage process and 
the tumor cells have to acquire several distinct properties 
either sequentially or in parallel.  
The first problem using NetLogo framework for 
simulation was using behavioral space which supports 
multithreading. In this way, performance is limited to the 
number of cores at the local infrastructure.  
To solve the local processing problem, we utilized the 
parametric simulations using a HPC cluster in order to 
reduce the necessary time to explore a determinate model 
data space.  
Since we needed to distribute our model through the 
distributed architecture to explore the model states in the 
microenvironment scale, it was revealed that NetLogo 
also has scalability issues in designing graph networks.  
Although there are available extensions for scaling up the 
model in the form of graph, it still depends on the size of 
the tumor and it could be a very slow process, taking days 
to finish experiment considering the checkpoints and 
performance bottlenecks while using a HPC cluster. 
We had to translate and move our model to a new 
framework such as the style and structure of Mesa to 
facilitate our distributed executions. 
The newest changes in the ground of the old scenario is 
increasing the population of agents, obtaining graph-
based representation of biological network and 
consideration of multi-state and multi-scale components 
(An2008).  
The initial design aspect of the multi-scale architecture 
of out tumor growth model in Python comes from the 
acute inflammation based on the key factors such as 
angiogenesis. Tumor angiogenesis is critical for tumor 
growth and maintenance (Kaur et al., 2005).  
Our new model strategy begins with an initial 
identification of a minor population of cells with the 
characteristics of “tumor-initiating” cancer stem cells 
and these cancer stem cells in the assumed tumor reside 
in close proximity to the blood vessels. Therefore, we 
chose an angiogenetic switch for our model which have 
to balance this dynamic. We had angiogenetic and anti-
angiogenetic factors. 
In the case of anti-angiogenetic, we will have the 
probability of quiescent tumor. In this agent-based 
model, tumor cells are affected, inflamed and turn 
quiescent.  
Table 1 shows the range of parameters we implemented 
to control the factors. 
Based on these factors, we can achieve a simulation 
evolution of metastasis and measure the tumor volume 
ratio along with the dynamics of the tumor under the 
influence of the factors. 
 
 
Table 1: different control factors of tumor growth 
Factors 
 Low Medium High 
Angiogenesis 0.0 0.4 1 
Recovery 0.1 0.3 1 
Quiescent 0.1 0.5 1 
 
To select a network topology for tumor model, we 
selected a random graph. Barabasi-Albert model is a 
scale-free network and it is one of the most basic models 
since it describes most of the biological networks - 
especially in evolutionary models; but since there is a 
need to manage the cell interactions and stromal cells 
behavior within the tumor microenvironment and due to 
the time-dependency of the connections, we developed 
our Python agent-based model on Erdös-Rényi topology. 
The visualization of the model is a network of nodes 
(using the Mesa architecture) that shows the distribution 
of agents and their links. Considering the architecture of 
Mesa, the creation of agents occurs based on the 
assignment of nodes to a graph. A scheduler (time 
module) activates agents and stores their locations and 
updates the network. 
The total operation time is directly related to the number 
of steps necessary to deploy all the agents. Since each 
agent changes in three states, the process goes on until 
the tumor agent's volume appears as metastasis. 
Thus, for P as a Probability and for edge creation in n 
number of nodes, if (Ps > log (n)/n)) almost all vertices 
are connected and this function returns a directed graph 
as we described in Algorithm 1.  
Erdös-Rényi model takes a number of vertices N and 
connecting nodes by selecting edges from the (N (N-1)/2) 
possible edges randomly. The pseudo-code generating a 
random network is described in Algorithm 1: 
 
Algorithm 1 
Input: (n,p, p* ) 
Output: (True, False) 
Begin Algorithm 
    For n in enumerate(nodes): 
        For p in enumerate(Ps): 
            If  p > p* then   
                 p_connected(n, p) = 1 
            Else 
                return 0 
            Endif 
        Endfor 
     Endfor 
End Algorithm 
 
 
The interactive visualization in Mesa helps us to identify 
insights and generate value from connected data. 
Considering the data analysis for life sciences such as 
tumor which is almost about connections and 
dependencies, the large amount of data makes it difficult 
for researchers to identify insights.  
Graph visualization makes large amounts of data more 
accessible and easier to read, as it has been illustrated in 
Figure 2. 
 
 
Figure 2: Graph visualization for three states (normal, 
dead and metastatic) shown in three colors 
 
 
Figure 3: Tumor stabilization challenges for cancer stem 
cells (CSC) with control factors more than medium 
 
Figure 3 shows the reduction of cancer stem cells in 550 
initial stem cells which are affected by control factors in 
the time it took, which was about 8 minutes for this 
simulation.  
Tumor growth curves are used for derivation of the 
Tumor Control Index (TCI), such as tumor progression, 
rejection and stabilization. We tried to combine both 
rejection and stabilization challenges to show the 
potential of Python agent-based modeling with different 
control factors.  
According to (Peskin 2009), we need a statistical method 
that leads to volume ratio measurements of tumor, as it 
could be seen in figure 3. To calculate tumor volume 
using (Monga.s 2000) we needed tumor width (W) and 
tumor length (L) which is presented in formula 1: 
 
 	 =  × 2 (1) 
 
This calculation which works pretty well for clinical 
issues, was made based upon the assumption that solid 
tumors are more or less spherical like the version we had 
before in Netlogo Wilensky’s tumor model, but not 
proper for the metastatic diseases, which due to the phase 
transition and spreading dynamics will be defined by 
graph presentations in the future. 
According to Rai (2017), the model which have the same 
size and number of connections as of a given network 
could maintain the degree sequence of the given network. 
By generating a random network with a given average 
degree (K) and initial size of tumor (N), we could 
construct degree sequence (m) and it is presented in 
formula 2: 
 
 =  ∑ 

          
N= 2, K={3,4,5,6,7,8} 
 
(2) 
 
 
For volume calculation, we start by assuming that every 
cell inside the tumor has three states (normal, dead and 
metastatic) which corresponds to tumor by edges. With 
the given K degree from three to eight and N initial 
nodes, we constructed an ER (Erdös-Rényi) network, 
whose degree sequence of (m) could lead us to the tumor 
volume ratio. 
The pseudo-code using the dynamic of degree sequence 
under the influence of above factors producing tumor 
volume in graph network is described in Algorithm 2: 
 
Algorithm 2 
Input: (N,K=3) 
Output: (Tumor Volume) 
Begin Algorithm 
    While  p_connected= 1  
              For N in nodes(G) 
                    If P  < Factor then                               
                                       Return m/n 
                    Endif            
               Endfor 
End Algorithm 
 
In Figure 4, we executed the model with different 
angiogenesis control factor in (0.1 to 0.9) for 60, 360, 
650, 100 and 1200 cancer stem cells (CSCs) to produce 
the tumor volume analysis based on the density 
distribution of the graph. 
 
 
Figure 3: Tumor Angiogenesis volume ratio for 60 to 
1200 cancer stem cell (CSC) 
4. CONCLUSION 
 
In summary, agent-based modeling in Python with Mesa 
project represents a valuable and time-saving simulation 
technique, which allowed us to re-implement our tumor 
model across a network based space.  
Mesa enable a modeler to quickly write down the code 
and quickly explore the results. Mesa also collect the 
results easily and help us in data integration which is very 
important in the case of phase transition and pattern-
oriented modeling. 
We migrated successfully from Netlogo to Python-Mesa, 
which will allow us to reintegrate our system quicker and 
reiterate simulations taken on previous system with more 
data in considerably less time. 
In the future, we will extend the model to run on cloud 
infrastructure in parallel. This could be an impressive 
achievement for fast analysis purposes in clinics, both on 
the predictive diagnostic and therapeutic side. 
As advantages of this contribution, we have a scalable 
model that together with Python can be distributed over 
an HPC architecture eliminating the limitations of other 
environments (e.g. Netlogo due to memory limitations of 
the JVM).  
When Python + Mesa can be deployed over an HPC 
architecture, there will be a notable increase in scalability 
and performance since, in this type of environment, the 
simulation will not be limited by memory. 
One of the most important disadvantages is the model 
visualization and animation for oncologists. Netlogo has 
a cells visualization and animation that can be useful to 
medical environments. Mesa only has the visualization 
of the network of agents and their interconnections, so 
graphic functions must be developed to see the evolution 
of the cells and the degree of metastasis/apoptosis and 
other relevant parameters for the medical analyst. 
Another important aspect that must be addressed will be 
the functional validation of the whole model since at this 
moment only a verification and partial validation of the 
behavior of the affected cells has been carried out. 
 
 
ACKNOWLEDGMENTS 
The MINECO Spain under contract TIN2014-53172-P 
and TIN2017-84875-P have supported this research. 
 
REFERENCES 
Wilensky, U., 1998. NetLogo Tumor model. Center for 
Connected Learning and Computer-Based 
Modeling, Northwestern University, Evanston, IL. 
Project Integrated Simulation & Model 
Environment. National Science Foundation REC-
9814682 and REC-0126227  
Li, S., & Li, S., 2014. Cancer stem cells and tumor 
metastasis (Review). International Journal of 
Oncology, 44, 1806-1812.  
Weis, S. M., & Cheresh, D. A., 2011. Tumor 
angiogenesis: Molecular pathways and therapeutic 
targets. Nature Medicine.  
Carmeliet, P., & Jain, R. K., 2000. Angiogenesis in 
cancer and other diseases. Nature.  
Thorne, B. C., Bailey, A. M., & Peirce, S. M., 2007. 
Combining experiments with multi-cell agent-
based modeling to study biological tissue 
patterning. Briefings in Bioinformatics.  
Edelman, L. B., Eddy, J. A., & Price, N. D., 2010. In 
silico models of cancer. Wiley Interdisciplinary 
Reviews: Systems Biology and Medicine.  
Soleimani, S., Shamsi, M., Ghazani, M. A., Modarres, H. 
P., Valente, K. P., Saghafian, M., Sanati-Nezhad, 
A., 2018. Translational models of tumor 
angiogenesis: A nexus of in silico and in vitro 
models. Biotechnology Advances.  
Tashakor, G., Luque, E., & Suppi, R., 2017. High 
Performance Computing for Tumor Propagation 
Agent-based Model.  
Granger, D. N., & Senchenkova, E, 2010. Inflammation 
and the Microcirculation. Colloquium Series on 
Integrated Systems Physiology: From Molecule to 
Function, 2(1), 1–87.  
Girvan, M., & Newman, M. E. J., 2002. Community 
structure in social and biological networks. Proc. 
Natl. Acad. Sci. USA, 99(12), 7821–7826.  
Tashakor, G., Suppi, R., 2017. HpcNetlogo. Frontend for 
the concurrent execution of Netlogo experiments 
using SGE HPC cluster.  
Cho, D.-Y., Kim, Y.-A., & Przytycka, T. M., 2012. 
Chapter 5: Network Biology Approach to Complex 
Diseases. PLoS Computational Biology, 8(12), 
e1002820.  
Masad, D., & Kazil, J., 2015. MESA: An Agent-Based 
Modeling Framework. Proceedings of the 14th 
Python in Science Conference.53–60.  
Xing, F., Eisele, J., Bastian, P., & Heermann, D. W., 
2015. Computational complexity of agent-based 
multi-scale cancer modeling. Simulation Series, 
47(10), 351–358.  
Villadsen, J., Jensen, A. S., Ettienne, M. B., Vester, S., 
Andersen, K. B., & Frøsig, A., 2013. 
Reimplementing a multi-agent system in python. In 
Lecture Notes in Computer Science (including 
subseries Lecture Notes in Artificial Intelligence 
and Lecture Notes in Bioinformatics) (Vol. 7837 
LNAI, pp. 205–216).  
An, G. 2008. Introduction of an agent-based multi-scale 
modular architecture for dynamic knowledge 
representation of acute inflammation. Theoretical 
Biology and Medical Modelling. 
Railsback, S. F., Lytinen, S. L., & Jackson, S. K., 2006. 
Agent-based Simulation Platforms: Review and 
Development Recommendations. Simulation, 
82(9), 609–623.  
 Bonabeau, E., 2002. Agent-based modeling: methods 
and techniques for simulating human systems. 
Proceedings of the National Academy of Sciences, 
99(suppl. 3), 7280–7287.  
Norton, K.-A., McCabe Pryor, M. M., & Popel, A. S., 
2015. Multiscale Modeling of Cancer. bioRxiv, 
33977.  
D., M., R.S., C., M., R., E.C., F., B., T., & I., R., 2011. 
Modeling formalisms in systems biology. AMB 
Express, 1(1), 1–14. 
Grimm, V., Revilla, E., Berger, U., Jeltsch, F., Mooij, W. 
M., Railsback, S. F, DeAngelis, D. L. (2005). 
Pattern-oriented modeling of agent-based complex 
systems: Lessons from ecology. Science.  
ALITALO, K., TAMMELA, T. and PETROVA, T.V. 
2005. Lymphangiogenesis in development and 
human disease. Nature 438: 946-953. 
Kerbel, Robert S., (2008). Tumor angiogenesis. New 
England Journal of Medicine 358.19 2039-2049. 
Peskin, A., Kafadar, K., Santos, A., & Haemer, G. 2009. 
Robust Volume Calculations of Tumors of Various 
Sizes. 
Monga, S. P. S., Wadleigh, R., Sharma, A., Adib, H., 
Strader, D., Singh, G. Mishra, L. 
2000.  Intratumoral therapy of cisplatin/epinephrine 
injectable gel for palliation in patients with 
obstructive esophageal cancer. American Journal 
of Clinical Oncology: Cancer Clinical 
Trials, 23(4), 386-392 
Rai, A., Pradhan, P., Nagraj, J., Lohitesh, K., 
Chowdhury, R., & Jalan, S. 2017. Understanding 
cancer complexome using networks, spectral graph 
theory and multilayer framework. Scientific 
Reports, 7. 
 
AUTHORS BIOGRAPHY 
 
GHAZAL TASHAKOR is Research Fellow and PhD 
Candidate for trainee research staff position (PIF) at the 
Computer Architecture & Operating Systems 
Department (CAOS) of the University Autònoma de 
Barcelona. Her research interests include high 
performance simulation, agent-based modelling and their 
applications, service systems, integration, resource 
consumption, and execution time. Her e-mail address is: 
ghazal.tashakor@caos.uab.cat 
 
REMO SUPPI received his diploma in Electronic 
Engineering from the Universidad Nacional de La Plata 
(Argentina), and the PhD degree in Computer Science 
from the Universitat Autonoma de Barcelona (UAB) in 
1996. At UAB, he spent more than 20 years researching 
on topics including computer simulation, distributed 
systems, high performance and distributed simulation 
applied to ABM or individual-oriented models. He has 
published several scientific papers on the topics above 
and has been the associate professor at UAB since 1997, 
also a member of the High Performance Computing for 
Efficient Applications and Simulation Research Group 
(HPC4EAS) at UAB. His email address is: 
remo.suppi@uab.cat. 
 
 
 
